Effects of Lisdexamfetamine Dimesylate Treatment for ADHD on Growth

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 49, Issue 1, 2010, Pages 24-32

  Faraone, Stephen V ^a   Spencer, Thomas J ^b   Kollins, Scott H ^c   Glatt, Stephen J ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amphetamine; attention deficit hyperactivity disorder; growth; lisdexamfetamine dimesylate; stimulants

Indexed keywords

LISDEXAMFETAMINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GROWTH CURVE; GROWTH RETARDATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OPTIMAL DRUG DOSE; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHOOL CHILD; SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CLINICAL TRIALS, PHASE III AS TOPIC; CROSS-OVER STUDIES; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 73649144242     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/00004583-201001000-00006     Document Type: Article

References (17)

1. Faraone S.V., Biederman J., Morley C.P., and Spencer T.J. Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 47 9 (2008) 994-1009
2. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113 4 (2004) 762-769
3. Swanson J.M., Elliott G.R., Greenhill L.L., et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry 46 8 (2007) 1015-1027
4. Faraone S.V., Biederman J., Monuteaux M., and Spencer T. Long-term effects of extended-release mixed amphetamine salts treatment of attention-deficit/hyperactivity disorder on growth. J Child Adolesc Psychopharmacol 15 2 (2005) 191-202
5. Spencer T., Faraone S.V., Biederman J., et al. Does prolonged stimulant therapy suppress growth in children with ADHD?. Analysis of data from 21 months of therapy with once-daily OROS® MPH. J Am Acad Child Adolesc Psychiatry 45 5 (2006) 527-537
6. Faraone S.V., and Giefer E.E. Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth. J Am Acad Child Adolesc Psychiatry 46 9 (2007) 1138-1147
7. Adler L.A., Goodman D.W., Kollins S.H., et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69 9 (2008) 1364-1373
8. Faraone S.V. Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder. Expert Opin Pharmacother 9 9 (2008) 1565-1574
9. Biederman J., Boellner S.W., Childress A., Lopez F.A., Krishnan S., and Zhang Y. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry 62 9 (2007) 970-976
10. Biederman J., Krishnan S., Zhang Y., McGough J.J., and Findling R.L. Efficacy and safety of lisdexamfetamine (LDX; NRP104) in children with attention-deficit/hyperactivity disorder: a phase 3, randomized, multicenter, double-blind, parallel-group study. Clin Ther 29 3 (2007) 450-463
11. Kuczmarski R.J., Ogden C.L., Guo L., et al. CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 11 246 (2000) 1-201
12. Swanson J., Greenhill L., Wigal T., et al. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry 45 11 (2006) 1304-1313
13. Schertz M., Adesman A.R., Alfieri N.E., and Bienkowski R.S. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Pediatrics 98 4, pt 1 (1996) 763-769
14. Satterfield J.H., Cantwell D.P., Schell A., and Blaschke T. Growth of hyperactive children treated with methylphenidate. Arch Gen Psychiatry 36 (1979) 212-217
15. Sund A.M., and Zeiner P. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?. Nord J Psychiatry 56 1 (2002) 53-57
16. Faraone S.V., and Giefer E.E. Long term effects of methylphenidate transdermal delivery system treatment of ADHD on growth. J Am Acad Child Adolesc Psychiatry 46 9 (2007) 1138-1147
17. Swanson JM, Ruff DD, Feldman PD, Furr AJ, Allen AJ. Characterization of growth in children with ADHD. Paper presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting; Toronto, Canada; 2005.